OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
5-(Trifluoromethyl)-1,2,4-oxadiazole (TFMO)-based highly selective class IIa HDAC inhibitors exhibit synergistic anticancer activity in combination with bortezomib
Yodita Asfaha, Lukas M. Bollmann, Alexander Jan Skerhut, et al.
European Journal of Medicinal Chemistry (2023) Vol. 263, pp. 115907-115907
Closed Access | Times Cited: 6
Yodita Asfaha, Lukas M. Bollmann, Alexander Jan Skerhut, et al.
European Journal of Medicinal Chemistry (2023) Vol. 263, pp. 115907-115907
Closed Access | Times Cited: 6
Showing 6 citing articles:
Exploring Alternative Zinc-Binding Groups in Histone Deacetylase (HDAC) Inhibitors Uncovers DS-103 as a Potent Ethylhydrazide-Based HDAC Inhibitor with Chemosensitizing Properties
Daniel Stopper, Lukas Biermann, P. R. Watson, et al.
Journal of Medicinal Chemistry (2025)
Closed Access | Times Cited: 2
Daniel Stopper, Lukas Biermann, P. R. Watson, et al.
Journal of Medicinal Chemistry (2025)
Closed Access | Times Cited: 2
Discovery of a potential hematologic malignancies therapy: Selective and potent HDAC7 PROTAC degrader targeting non-enzymatic function
Yuheng Jin, Xuxin Qi, Xiaoli Yu, et al.
Acta Pharmaceutica Sinica B (2025)
Open Access
Yuheng Jin, Xuxin Qi, Xiaoli Yu, et al.
Acta Pharmaceutica Sinica B (2025)
Open Access
Drug Discovery for Histone Deacetylase Inhibition: Past, Present and Future of Zinc-Binding Groups
Gustavo Salgado Pires, Heber Victor Tolomeu, Daniel A. Rodrigues, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 4, pp. 577-577
Open Access
Gustavo Salgado Pires, Heber Victor Tolomeu, Daniel A. Rodrigues, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 4, pp. 577-577
Open Access
Unveiling the therapeutic potential of 1,2,4-oxadiazole derivatives: An updated review
Hussam Elddin Nabeih Khasawneh, Ali Abdulrazzaq Abdulhussein Alrikabi, Amran M. AL-Erjan, et al.
Results in Chemistry (2025), pp. 102271-102271
Open Access
Hussam Elddin Nabeih Khasawneh, Ali Abdulrazzaq Abdulhussein Alrikabi, Amran M. AL-Erjan, et al.
Results in Chemistry (2025), pp. 102271-102271
Open Access
Synthesis and biological evaluation of ortho -phenyl phenylhydroxamic acids containing phenothiazine with improved selectivity for class IIa histone deacetylases
Kai‐Cheng Hsu, Yunyi Huang, Jung-Chun Chu, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2024) Vol. 39, Iss. 1
Open Access
Kai‐Cheng Hsu, Yunyi Huang, Jung-Chun Chu, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2024) Vol. 39, Iss. 1
Open Access
Novel Ag(I)‐based 1,2,4‐Oxadiazole Complexes: Synthesis, X‐Ray Crystal Structure, and Biological Evaluation as Anticancer Candidates
Mohammed Salah Ayoup, Rabia E. Alashhab, Saied M. Soliman, et al.
Applied Organometallic Chemistry (2024) Vol. 39, Iss. 2
Closed Access
Mohammed Salah Ayoup, Rabia E. Alashhab, Saied M. Soliman, et al.
Applied Organometallic Chemistry (2024) Vol. 39, Iss. 2
Closed Access
